GSK547
GSK547 (GSK'547) is a highly selective and potent inhibitor of receptor-interacting serine/threonine protein kinase 1 (RIPK1), inhibits macrophage-mediated adaptive immune tolerance in pancreatic cancer[1].
Product Specifications
CAS Number
2226735-55-1
Product Name Alternative
GSK'547
UNSPSC
12352005
Hazard Statement
H315, H319, H320
Target
RIP kinase
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/gsk547.html
Concentration
10mM
Purity
99.92
Solubility
DMSO : 175 mg/mL (ultrasonic)
Smiles
N#CC1=NC=NC(N2CCC(C(N3N=CC[C@H]3C4=CC(F)=CC(F)=C4)=O)CC2)=C1
Molecular Formula
C20H18F2N6O
Molecular Weight
396.39
Precautions
H315, H319, H320
References & Citations
[1]Wang W, et al. RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer. Cancer Cell. 2018 Nov 12;34 (5) :757-774.e7.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
RIPK1
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Cyclin D1 (CCND1/809), CF594 conjugate, 0.1mg/mL
